Verbal Identity

Trademarks & Standards

blue background with graphic element

Overview

Use the full product name in the first mention (include ® or ™ in the name for the first use only) in any document. This first use should be shown exactly how it’s shown in the “Product Names, Abbreviations and Related” table below. After that, abbreviations can be used. Follow the “Trademark Usage Rules” below when using trademarked names.

Trademark Application

Include a trademark footer at the end of your document: ©YYYY Veracyte, Inc. The trademarks mentioned herein are the property of Veracyte (for a non-exhaustive list, see www.veracyte.com/trademarks) or their respective owners. (YYYY is the year the content was published). This statement can be omitted in scientific publications and press releases.

Do

Use the appropriate full name in the table below:

  • Decipher® Prostate Genomic Classifier was used to test patients at 12 months in this cohort.

Don't

Use trademarks to modify nouns not referring to the product they are intended for

  • Patients in the Decipher cohort were tested at 12 months.

Do

Use ™ until Legal confirms the trademark is registered was used in this study

  • TrueMRD™ Monitoring Test for Muscle-Invasive Bladder Cancer was used in this study.

Don't

Use ® if a trademark is not confirmed registered

  • TrueMRD® Monitoring Test for Muscle-Invasive Bladder Cancer was used in this study.

Do

Trademarks are adjectives followed by a noun

  • Decipher® Prostate Genomic Classifier is a genomic test.
  • This cohort was tested using Decipher® Prostate Genomic Classifier (“Genomic Test”).
  • Exception: when a wordmark is used, a noun is not needed.

Don't

Use trademarks as nouns or verbs

  • Decipher® is a genomic test.
  • NCCN guidelines recommend molecular tumor analysis with advanced tools such as Decipher.
  • Deciphering this cohort resulted in the following data.

Do

Trademarks are adjectives followed by a noun

  • Decipher® Score.

Don't

Use trademarks in the possessive tense

  • Decipher’s score.

Exception: Veracyte can be used in the possessive tense. E.g. Veracyte’s tests are excellent.

Do

Use appropriate abbreviations provided below

  • Decipher® Prostate Genomic Classifier (“GC”) was used for this study.

Don't

Use trademarks in the possessive tense

  • Decipher® Prostate Genomic Classifier (“Decipher”) was used for this study.

Do

Trademarks should be upper case

  • Decipher® Prostate Genomic Classifier

Don't

Trademarks should never be lowercase

  • decipher test

Do

Use the correct names and rephrase accordingly

  • Decipher® Prostate Genomic Classifier (Veracyte) was used in this study.

Don't

Do not stack trademarks next to each other.

  • Veracyte Decipher Prostate Genomic Classifier was used in this study.

Product Names, Abbreviations and Related

Full product name

Decipher® Bladder Genomic Classifier

Abbreviation

Decipher Bladder
Decipher Bladder Test

Related names

Result:

Decipher Bladder Cancer Subtype
Decipher Bladder report

GRID:

Decipher Bladder GRID
Decipher Bladder GRID report
Decipher Bladder GRID database
Decipher Bladder GRID research tool

Full product name

Decipher® Prostate Genomic Classifier

Abbreviation

Decipher Prostate
Decipher Prostate Test

Related names

Result:

Decipher Prostate Genomic score
Decipher Genomic score
Decipher score
Decipher report
Decipher Genomic Risk Group

GRID:

Decipher® Prostate GRID
Decipher® Prostate GRID report
Decipher® Prostate GRID database
Decipher® Prostate GRID research tool

Full product name

Afirma® Genomic Sequencing Classifier

Retired names (do not use going forward):

Afirma Gene Expression Classifier (GEC) Afirma Xpression Atlas (XA)

Afirma GEC

Afirma Thyroid FNA Analysis

Abbreviation

Afirma® Thyroid
Afirma® GSC
Afirma® Thyroid Test

Related names

Result:

Afirma result
Afirma GSC result
Afirma report
GSC result (suspicious/benign)
Ensemble Classifier result
XA result

GRID:

Afirma GRID
Afirma GRID report
Afirma GRID database
Afirma GRID research tool

Full product name

Prosigna® Breast Cancer Assay

Retired name (do not use going forward):

Prosigna Breast Cancer Prognostic Gene Signature Assay

Abbreviation

Prosigna Breast
Prosigna Breast Test

Related names

Result:

Prosigna Breast Cancer Probability of Distant Recurrence
Prosigna Breast Risk of Recurrence (ROR)
Prosigna Breast Risk of Recurrence (ROR) score,*
Prosigna Breast Cancer Subtype, Prosigna score
Prosigna report

*Please make sure that “(ROR)” appears in the exact location shown above.

GRID:

Prosigna GRID
Prosigna GRID report
Prosigna GRID database
Prosigna GRID cohort/study report

Signature:

PAM50

‍****Please use PAM50 to refer only to the signature (not the test)

Full product name

Percepta® Nasal Swab Test

Abbreviation

Percepta Nasal Swab
PNS

Related names

Result:

Percepta Nasal Swab result
Percepta Nasal Swab Classifier
Percepta Nasal Swab report

Full product name

TrueMRD™ Monitoring Test for Muscle-Invasive Bladder Cancer

Abbreviation

TrueMRD Test
TrueMRD Test
TrueMRD for MIBC

Related names

Result:

TrueMRD result

(positive/negative)

Have questions

If you have questions regarding the guidance given here, contact brand@veracyte.com.

Last updated

January 5, 2026